J&J's consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut

Kenvue's debut is the biggest U.S. IPO since EV maker Rivian went public in 2021.

from Health and Science https://ift.tt/k1tCdca
https://ift.tt/fubjaCh
https://ift.tt/IAaxiTB